Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

157.20
Delayed Data
As of Feb 27
 +0.25 / +0.16%
Today’s Change
86.00
Today|||52-Week Range
172.98
+36.77%
Year-to-Date
Institutional investors purchased a net $2.9 million shares of SLXP during the quarter ended September 2014 and now own 112.78% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Other institutional67.29%
Mutual fund holders45.49%
Individual stakeholders12.81%

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

12/31/2014PAULSON & CO., INC.  Bought 5.8 Million shares of Salix Pharmaceuticals Ltd
12/31/2014JANUS CAPITAL MANAGEMENT LLC  Bought 1.5 Million shares of Salix Pharmaceuticals Ltd
12/31/2014MORGAN STANLEY & CO. LLC  Bought 1.4 Million shares of Salix Pharmaceuticals Ltd

Top 10 Owners of Salix Pharmaceuticals Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Paulson & Co., Inc.9.11%5,806,000781,894,020+5,806,000--
BlackRock Fund Advisors7.10%4,523,395609,165,605+61,478+1.38%
The Vanguard Group, Inc.5.94%3,784,309509,632,893+135,571+3.72%
Visium Asset Management LP4.83%3,076,092414,257,310+774,463+33.65%
SSgA Funds Management, Inc.3.43%2,187,382294,574,734+347,935+18.92%
Viking Global Investors LP2.73%1,738,104234,070,466-981,434-36.09%
Morgan Stanley & Co. LLC2.42%1,542,029207,665,045+1,362,607+759.44%
OppenheimerFunds, Inc.2.37%1,509,598203,297,563+1,183,795+363.35%
Pentwater Capital Management LP2.36%1,505,000202,678,350-495,000-24.75%
Janus Capital Management LLC2.34%1,487,848200,368,490+1,487,848--

Top 10 Mutual Funds Holding Salix Pharmaceuticals Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Vanguard Total Stock Market Index...1.64%1,042,451140,386,876+25,028+2.46%
iShares Core S&P Mid Cap ETF1.51%962,320129,595,634+17,036+1.80%
CREF Stock Account1.32%837,733112,817,503-211,849-20.18%
iShares Nasdaq Biotechnology ETF1.19%759,522102,284,828+4,165+0.55%
SPDR S&P Mid Cap 400 ETF Trust0.95%603,39581,259,205-121-0.02%
Vanguard Extended Market Index Fu...0.94%598,68880,625,313+11,930+2.03%
Janus Fund0.89%567,94876,485,557+567,948--
Hartford Mid Cap Fund0.89%567,93676,483,941+14,188+2.56%
Vanguard Mid Cap Index Fund0.86%550,54174,141,356+9,033+1.67%
T Rowe Price Health Sciences Fund0.86%550,50074,135,835+550,500--

To view my watchlist

Not a member yet?

Sign up now for a free account